The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

The purchase price is €6.25 per share of equity, putting the transaction value at €256.8 million for the 85.6% stake.

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Zydus Lifesciences Ltd on Wednesday (March 12) the company's venture capital arm Zynext Ventures USA LLC has announced an ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

Zydus Lifesciences has received USFDA approval to manufacture its generic version of Methenamine Hippurate tablets for ...

India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...